These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32443295)
21. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035 [TBL] [Abstract][Full Text] [Related]
22. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians. Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831 [TBL] [Abstract][Full Text] [Related]
23. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Lajin B; Alachkar A Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519 [TBL] [Abstract][Full Text] [Related]
24. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population. Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504 [TBL] [Abstract][Full Text] [Related]
25. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis. Gong M; Yi Q; Wang W Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485 [TBL] [Abstract][Full Text] [Related]
26. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672 [TBL] [Abstract][Full Text] [Related]
27. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106 [TBL] [Abstract][Full Text] [Related]
28. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population. Peng XE; Jiang YY; Shi XS; Hu ZJ Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878 [TBL] [Abstract][Full Text] [Related]
29. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning]. Sun P; Zhang Z; Wan J; Shao M Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838 [TBL] [Abstract][Full Text] [Related]
30. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects. Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623 [TBL] [Abstract][Full Text] [Related]
31. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis. Liu Y; Zhang D Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995 [TBL] [Abstract][Full Text] [Related]
32. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors]. Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302 [TBL] [Abstract][Full Text] [Related]
33. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis. Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139 [TBL] [Abstract][Full Text] [Related]
34. Role of NQO1 Gene Involvement and Susceptibility of T2DM Among Saudi Arabia Population. Alhaji JH; Pathak D; Ashfaq F; Alsayegh AA; Khatoon F; Almutairi BJ; Khan MI; Beg MMA Rejuvenation Res; 2024 Oct; 27(5):145-153. PubMed ID: 38959119 [TBL] [Abstract][Full Text] [Related]
35. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley. Malik MA; Zargar SA; Mittal B DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640 [TBL] [Abstract][Full Text] [Related]
36. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner. Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082 [TBL] [Abstract][Full Text] [Related]
37. Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors. Sarutipaiboon I; Settasatian N; Komanasin N; Kukongwiriyapan U; Sawanyawisuth K; Intharaphet P; Senthong V; Settasatian C Cardiovasc Toxicol; 2020 Apr; 20(2):176-189. PubMed ID: 31332605 [TBL] [Abstract][Full Text] [Related]
38. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis. Zhao HY; Gu Y; Yi YX Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529 [TBL] [Abstract][Full Text] [Related]
39. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India. Mandal RK; Nissar K; Mittal RD Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000 [TBL] [Abstract][Full Text] [Related]